FierceBiotechOriginal article
{"a":[{"_":"After slimming down workforce, Aardvark scraps phase 3 trials as wait for next steps drags on","$":{"href":"/biotech/slimmed-down-aardvark-scraps-phase-3-trials-wait-next-steps-drags","hreflang":"en"}}]}
Phase 3negativeNegative
AI Analysis
Summary
Aardvark Therapeutics has terminated its phase 3 trials and confirmed it will not resume the studies as previously designed, signaling a significant setback for its stalled pipeline following recent workforce reductions.
Clinical Trial Data
Phase
Phase 3
Outcome Details
Phase 3 trials terminated and company confirmed it will not resume the studies as previously designed
Importance:7/10
Sentiment:
-0.85
Phase 3 terminationpipeline stalledworkforce reductionclinical trial discontinuation
Read the original article
Published by FierceBiotech on August 12, 2026 9:04 AM